The invention relates to an injection device that is equipped with an apparatus for indicating an injection dose that has been set.
Ambiguous indications must not occur with such injection devices, since injection devices are often used by persons with poor vision, for example by diabetics, for whom an unequivocal display is extremely important, in order to avoid improper operation.
It is therefore an object of the invention to make available a novel injection device which militates against improper operation.
According to the invention, this object is achieved by equipping the injection device with a housing having a first window therein, a graduation carrier bearing dose values arranged on its surface in a helical configuration, a longitudinally displaceable second window in the housing, and respective lenses in the first and second windows, such that the first lens by itself distorts the dose values but the first and second lenses interact to render a single dose value legible, thereby militating against incorrect readings of the dose value selected by the user. Only at the point, where the first transparent lens arrangement and the second transparent lens arrangement interact, is it possible for a readily legible display, of the dose that has been set, to be visible; whereas at points where only the first transparent lens arrangement, but not the second, is effective, the visible, but optically distorted, dose values do not permit a legible reading, and thereby militate against improper settings of the injection dose.
Further details and advantageous refinements of the invention are evident from the exemplifying embodiment, in no way to be understood as a limitation of the invention, that is described below and depicted in the drawings.
The terms “proximal” and “distal” are used in the manner that is usual in medicine, i.e. proximal=close to the patient (the end having needle 48), distal=away from the patient (the end having setting knob 34).
Upper housing part 38 has a first window 50 (
Upper delimiter 56 acts as a stop for the maximum dose, which here is equal to approximately 60 units; and lower delimiter 58 acts as a stop for the zero dose, which is reached automatically after an injection. (This is depicted in
When graduated tube 60 is rotated by means of setting knob 34, it therefore brings about, using the two threads 64, 66, an axial displacement of inner sleeve 52 and thus of second window 54, specifically synchronously with the rotation of graduated tube 60, so that each dose indication of graduated tube 60 corresponds to a specific axial position of second window 64 relative to first window 50. An unequivocal dose indication thus results with this embodiment, since only the dose quantity, that is set, can be read in window 54.
If threaded sleeve 52 is short for design-related reasons, it may cover not the entire graduated tube 60 but only its upper part, as depicted in
This is because, in certain cases, the overall length of injector 30 must be minimized, so that the length of inner sleeve 52 (having window 54) cannot cover scale 62′ on its proximal region close to the patient. If this were the case, then in fact only the dose that has been set would be visible in window 54. For space reasons, however, this is not possible (see
This problem is solved by using housing part 38 having said first window 50, in which inner sleeve 52 having second window 54 is arranged in longitudinally displaceable fashion. Window 54 has an upper delimiter 56 and a lower delimiter 58. Indicator arrows 55, 57 that indicate the injection dose that has been set (see
Because the proximal part of scale 62′ on graduated tube 60 can no longer, because of the minimized length of inner sleeve 52, be completely covered upon axial displacement of inner sleeve 52 in a distal direction, not only the dose that has been set, but instead all the numbers of scale 62′, would be visible in the proximal region, close to the patient, of first window 50, since they are no longer concealed by inner sleeve 52.
For patients with poor vision, for example diabetics, this leads to the risk of misreading, i.e. in the case of, for example, the dose setting in accordance with
Such problems can be avoided with the configuration according to
Here a first lens system 80, depicted in
As
As
Arrangement 90 is inserted into window 54 of inner sleeve 52, for example by being clipped or adhesively bonded in. Its lower side 92 is cylindrical or flat (not depicted), and its upper side has valleys 94 extending in a longitudinal direction and longitudinal ridges 96, which extend in complementary fashion to elevations 86 and depressions 88 of
Second lens arrangement 90 is displaceable in a longitudinal direction relative to first lens arrangement 80, so that the visible region within second window 54 migrates axially when graduated tube 60 is rotated for dose setting purposes. In this manner, only the dose value that is presently set can be read clearly, as depicted by way of example in
(Be it noted, in this connection, that this optical effect is difficult to depict graphically.)
This improved legibility is achieved by the interaction of lens arrangement 100 with a mechanical setting apparatus. Incorrect settings are thereby reliably avoided, resulting in a readily understandable mode of operation.
Numerous variants and modifications are of course possible within the scope of the present invention. For example, inner sleeve 52 can likewise be made of transparent plastic, and can be formed integrally with second lens arrangement 90. It is particularly advantageous that, in the version according to
Numerous variants and modifications are of course possible, within the scope of the present invention.
Number | Date | Country | Kind |
---|---|---|---|
20 2008 011 175.7 | Aug 2008 | DE | national |
The present application is a section 371 of PCT/EP09/05123, filed 15 Jul. 2009, which in turn claims priority from German application DE 20 2008 011 175.7, filed 18 Aug. 2008, the disclosure of which is hereby incorporated by reference.
Filing Document | Filing Date | Country | Kind | 371c Date |
---|---|---|---|---|
PCT/EP2009/005123 | 7/15/2009 | WO | 00 | 4/27/2010 |